CHOC researchers seek to study the role of Tregs in whether pediatric leukemia patients treated with CAR T-cell therapy experience a relapse.
Colorful comics aid young patients in understanding and providing assent for participation in research studies to advance treatments.
The strength and positivity of pediatric cancer patients inspire Dr. Rishi Chavan, and the entire CHOC Cancer Institute, daily.
The oncology team at CHOC is overcoming common challenges — and delivering survival outcomes better than the national average.
Practicing self-compassion has never been more important for providers than during the COVID-19 pandemic, a CHOC oncologist writes.
Dr. Chavan’s clinical interests include stem cell transplant and immunotherapy for high risk leukemias/lymphomas.